| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 29 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.78M | - | |
| Dir | 164.0K | $12.46M | -8,000 | |
| VP | 100.3K | $7.62M | - | |
| VP | 83.3K | $6.33M | -60,846 | |
| CFO | 82.7K | $6.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2019 | Crooke Stanley T | Chairman And CEO | Sale+OE | 22,000 | $71.52 | $1,573,500.00 | -13.2% | |
| Jul 18, 2019 | Crooke Stanley T | Chairman &CEO | Sale+OE | 10,000 | $70.25 | $702,506.00 | -12.6% | |
| Jul 2, 2019 | Monia Brett P60 | Chief Operating Officer | Sell | 210 | $66.40 | $13,944.00 | -0.9% | |
| Jun 24, 2019 | Berthelsen Spencer R | Director | Sale+OE | 15,000 | $63.67 | $955,112.66 | -7.4% | |
| Jun 4, 2019 | Muto Frederick T | Director | Sale+OE | 15,000 | $65.29 | $979,350.00 | -60.5% | |
| May 6, 2019 | Muto Frederick T | Director | Sale+OE | 8,000 | $72.75 | $582,001.60 | -45.0% | |
| Apr 29, 2019 | Parshall B Lynne74 | Director | Sale+OE | 50,000 | $75.01 | $3,750,635.00 | -48.7% | |
| Apr 16, 2019 | Crooke Stanley T | Chairman And CEO | Sale+OE | 32,000 | $84.84 | $2,714,999.84 | -12.4% | |
| Apr 8, 2019 | Geary Richard S65 | SVP, Development | Sale+OE | 46,240 | $84.01 | $3,884,752.80 | -41.8% | |
| Apr 5, 2019 | O'Neil Patrick R.57 | SVP Legal &General Counsel | Sale+OE | 49,528 | $83.99 | $4,160,075.12 | -20.7% |